3-(benzo[d][1,3]dioxo-6-yl)-1-p-tolylprop-2-en-1-one | 37620-38-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 3-(benzo[d][1,3]dioxo-6-yl)-1-p-tolylprop-2-en-1-one
• 英文别名: 3,4-methylenedioxy-4'-methylchalcone；3-benzo[1,3]dioxol-5-yl-1-p-tolyl-propenone；4'-methyl-3,4-methylenedioxy-chalcone；4'-Methyl-3,4-methylendioxy-chalkon；3-(1,3-Benzodioxol-5-yl)-1-(4-methylphenyl)-2-propen-1-one；3-(1,3-benzodioxol-5-yl)-1-(4-methylphenyl)prop-2-en-1-one
• CAS: 37620-38-5
• 化学式: C₁₇H₁₄O₃
• 分子量: 266.296
• InChiKey: JWGMSRAHCNKMBC-UHFFFAOYSA-N

物化性质

• 熔点：
  32 °C(Solv: benzene (71-43-2); hexane (110-54-3))
• 沸点：
  434.0±45.0 °C(Predicted)
• 密度：
  1.225±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(benzo[d][1,3]dioxo-6-yl)-1-p-tolylprop-2-en-1-one 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 4.0h， 生成
  参考文献：
  名称：

  Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors

  摘要：

  A series of novel pyrazoline-containing derivatives (15-47) has been designed, synthesized and evaluated for their biological activities. Among them, compound 18 displayed the most potent antiproliferative activity against A549, MCF-7 and HepG-2 cells line (IC50 = 0.07 mu M, 0.05 mu M, 0.03 mu M, respectively) and the tubulin polymerization inhibitory activity (IC50 = 1.88 mu M), being comparable to CA-4. Furthermore, we also tested that compound 18 was a potent inducer of apoptosis in HepG-2 cells and it had cellular effects typical for microtubule interacting agents, causing accumulation of cells in the G2/M phase of the cell cycle. These studies, along with molecular docking, provided a new molecular scaffold for the further development of antitumor agents that target tubulin. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.02.058
• 作为产物：
  描述：

  5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide 在 potassium carbonate 、 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 8.0h， 生成 3-(benzo[d][1,3]dioxo-6-yl)-1-p-tolylprop-2-en-1-one
  参考文献：
  名称：

  以苯并二恶唑为潜在抗癌剂的噻唑基-吡唑啉衍生物的合成，分子对接和评价

  摘要：

  已经设计并合成了一系列含有苯并二恶唑（C1-C20）的新型噻唑基-吡唑啉衍生物。在合成的化合物中，2-（5-（苯并[ d ] [1,3]二恶酚-5-基）-3-（4-溴苯基）-4,5-二氢-1 H-吡唑-1-基）-4-（4-溴苯基）噻唑（C6）对HER-2表现出最强的抑制活性（HER-2的IC 50  = 0.18μM）。抗增殖试验结果表明，化合物C6在体外对MCF-7和B16-F10具有很高的抗增殖活性，IC 50值分别为0.09和0.12μM，与阳性对照厄洛替尼相当。进一步进行对接仿真以确定可能的结合模型。根据初步结果，在肿瘤生长中具有强抑制活性的化合物C6将是潜在的抗癌药。

  DOI：

  10.1016/j.bmc.2012.11.020

文献信息

• Co–N–C Catalyst for C–C Coupling Reactions: On the Catalytic Performance and Active Sites
  作者：Leilei Zhang、Aiqin Wang、Wentao Wang、Yanqiang Huang、Xiaoyan Liu、Shu Miao、Jingyue Liu、Tao Zhang

  DOI：10.1021/acscatal.5b01223

  日期：2015.11.6

  simple substrates. However, they usually involve the employment of organic halides and suffer from toxic or environmental issues. We report an efficient and environmentally benign methodology—aerobic oxidative cross-coupling of primary and secondary alcohols—to directly produce α,β-unsaturated ketones that are key intermediates for synthesis of agrochemical, pharmaceutical, and other fine chemicals. A noble-metal-free

  C–C键形成反应在化学中对于从容易获得的简单底物构建复杂大分子非常重要。但是，它们通常涉及有机卤化物的使用，并且具有毒性或环境问题。我们报告了一种有效且对环境无害的方法-伯醇和仲醇的好氧氧化交叉偶联-直接生产α，β-不饱和酮，这是合成农业化学，制药和其他精细化学品的关键中间体。一种无贵金属的Co–N–C催化剂，是由钴-菲咯啉配合物在中孔碳载体上热解衍生而来的，可用于目标反应，并具有很高的催化活性（转换频率为3.8 s –1基于Co的单原子，超过了文献中的技术水平），良好的可回收性以及对各种基材的广泛适用性（28个示例）。有人建议在Co–N–C催化剂中的活性位是在石墨薄片内与N键合的Co单原子。
• A Novel Series of 3,4-Disubstituted Dihydropyrazoles: Synthesis and Evaluation for MAO Enzyme Inhibition
  作者：Maria Cristina Cardia、Maria Luisa Sanna、Rita Meleddu、Simona Distinto、Matilde Yañez、Dolores Viña、Manuel Lamela、Elias Maccioni

  DOI：10.1002/jhet.1072

  日期：2013.2

  In this study, the authors have designed and synthesized a novel series of 3-acyl-4-aryl-4,5-dihydropyrazoles, with the aim to obtain new potential scaffolds for the inhibition of both isoforms of monoamine oxidase (MAO) enzyme. The synthetic pathway to these compounds includes as a key step the 1,3-dipolar cycloaddition reaction of diazomethane with a chalcone. All the compounds were fully characterized

  在这项研究中，作者设计并合成了一系列新的3-酰基-4-芳基-4,5-二氢吡唑类化合物，目的是获得新的抑制单胺氧化酶（MAO）两种同工型的潜在支架。这些化合物的合成途径包括关键步骤：重氮甲烷与1,3-偶极甲烷的1,3-偶极环加成反应。查尔酮。所有化合物均通过光谱和分析数据充分表征，并显示出对MAO A的特异性抑制作用。
• Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation
  作者：Xiao-Qiang Yan、Zhong-Chang Wang、Bo Zhang、Peng-Fei Qi、Gui-Gen Li、Hai-Liang Zhu

  DOI：10.3390/molecules24091685

  日期：——

  Cyclooxygenase-2 (COX-2) as a rate-limiting metabolism enzyme of arachidonic acid has been found to be implicated in tumor occurrence, angiogenesis, metastasis as well as apoptosis inhibition, regarded as an attractive therapeutic target for cancer therapy. In our research, a series of dihydropyrazole derivatives containing benzo oxygen heterocycle and sulfonamide moieties were designed as highly potent

  已发现环氧合酶-2 (COX-2) 作为花生四烯酸的限速代谢酶与肿瘤发生、血管生成、转移以及细胞凋亡抑制有关，被认为是癌症治疗的有吸引力的治疗靶点。在我们的研究中，通过对已知 COX-2 抑制剂的计算机辅助药物分析，将一系列含有苯并氧杂环和磺酰胺部分的二氢吡唑衍生物设计为高效且选择性的 COX-2 抑制剂。共合成了26种化合物，多角度评价了体外和体内COX-2抑制作用和药理效率。其中，化合物4b对SW620细胞表现出最优异的抗增殖活性，IC50比塞来昔布（IC50 = 1.29±0.04 µM）为0.86±0.02 µM。
• 4,5-Dihydropyrazole derivatives containing oxygen-bearing heterocycles as potential telomerase inhibitors with anticancer activity
  作者：Yin Luo、Yang Zhou、Jie Fu、Hai-Liang Zhu

  DOI：10.1039/c4ra02200a

  日期：——

  Telomere and telomerase were closely related to the occurrence and development of some cancers. After the key active site of telomerase was identified, to enhance the ability of dihydropyrazole derivatives to inhibit telomerase, we designed a series of novel 4,5-dihydropyrazole derivatives containing heterocyclic oxygen moiety based on previous studies. The telomerase inhibition assay showed that compound 10a displayed the most potent inhibitory activity with an IC50 value of 0.6 μM for telomerase. The antiproliferative assay showed that 10a exhibited high activity against human gastric cancer cell SGC-7901 with an IC50 value of 10.95 ± 0.60 μM. Flow cytometric analysis and western blot results showed that 10a induced both apoptosis and autophagy. A docking simulation showed that 10a could bind well to the active site of telomerase and act as a telomerase inhibitor. The 3D-QSAR model was also built to provide a more pharmacological understanding that could be used to design new agents with more potent telomerase inhibitory activity.

  端粒和端粒酶与某些癌症的发生发展密切相关。在鉴定出端粒酶关键活性部位后，基于以往的研究，为了增强二氢吡唑衍生物抑制端粒酶的能力，我们设计了一系列含有杂环氧基的新型4,5-二氢吡唑衍生物。端粒酶抑制实验表明，化合物10a显示出最强的抑制活性，其对端粒酶的IC50值为0.6 μM。细胞增殖实验表明，10a对胃癌细胞SGC-7901具有很高的活性，其IC50值为10.95 ± 0.60 μM。流式细胞分析和western blot结果显示，10a可诱导细胞凋亡和自噬。对接模拟显示，10a可与端粒酶的活性位点很好地结合，并作为端粒酶抑制剂发挥作用。同时，为了能更好地指导设计出新的具有更强端粒酶抑制活性的化合物，我们构建了三维定量构效关系(3D-QSAR)模型。
• Antimycobacterial and Anti-Inflammatory Activities of Substituted Chalcones Focusing on an Anti-Tuberculosis Dual Treatment Approach
  作者：Thatiana Ventura、Sanderson Calixto、Bárbara Abrahim-Vieira、Alessandra Souza、Marcos Mello、Carlos Rodrigues、Leandro Miranda、Rodrigo de Souza、Ivana Leal、Elena Lasunskaia、Michelle Muzitano

  DOI：10.3390/molecules20058072

  日期：——

  isolate as well. In silico analysis of ADMET properties showed that the evaluated chalcones displayed satisfactory pharmacokinetic parameters. In conclusion, the obtained data demonstrate that at least two of the studied chalcones, compounds 4 and 5, are promising antimycobacterial and anti-inflammatory agents, especially focusing on an anti-tuberculosis dual treatment approach.

  结核病 (TB) 仍然是一个严重的公共卫生问题，由于对多种药物 (MDR) 具有抗药性的结核分枝杆菌 (Mtb) 菌株的出现而加剧。MDR-TB 病例中常见的 TB 治疗延迟会导致易感的高反应性个体发生危及生命的有害炎症，这鼓励了新的抗 Mtb 药物的发现和基于抗炎干预的辅助治疗的使用。在这项研究中，一系列四十种合成查耳酮在体外评估了它们的抗炎和抗分枝杆菌特性，并在计算机上评估了药代动力学参数。七种化合物分别通过特异性抑制 iNOS 和 COX-2 表达，强烈抑制 LPS 刺激的巨噬细胞产生 NO 和 PGE2，其中化合物 4 和 5 在这方面表现突出。七种最活跃的化合物中有四种能够抑制 TNF-α 和 IL-1β 的产生。测试对培养的巨噬细胞无毒的查耳酮的抗分枝杆菌活性。八种化合物能够抑制细菌培养物和感染巨噬细胞中牛分枝杆菌 BCG 和 Mtb H37Rv 菌株的生长。其中四种，包括化合物